
Article 1 
The approval of the low-risk active substance laminarin is renewed as set out in Annex I.
Article 2 
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.
Article 3 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
It shall apply from 1 March 2018.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 24 January 2018.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX I

Common Name, Identification Numbers IUPAC Name Purity Date of approval Expiration of approval Specific provisions
LaminarinCAS No 9008-22-4CIPAC No 671 (1→3)-β-D-glucan(according to IUPAC-IUB Joint Commission on Biochemical Nomenclature) ≥ 860 g/kg on dry matter (TC) 1 March 2018 28 February 2033 For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on laminarin, and in particular Appendices I and II thereto, shall be taken into account.Conditions of use shall include risk mitigation measures, where appropriate.

ANNEX II

The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

((1)) in Part A, the entry 95 on laminarin is deleted;
((2)) in Part D, the following entry is added:

Number Common Name, Identification Numbers IUPAC Name Purity Date of approval Expiration of approval Specific provisions
‘12 LaminarinCAS No 9008-22-4CIPAC No 671 (1→3)-β-D-glucan(according to IUPAC-IUB Joint Commission on Biochemical Nomenclature) ≥ 860 g/kg on dry matter (TC) 1 March 2018 28 February 2033 For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on laminarin, and in particular Appendices I and II thereto, shall be taken into account.Conditions of use shall include risk mitigation measures, where appropriate.’

